72 web-programmer-developer-"https:"-"https:"-"https:"-"University-of-Kent" positions at UNIVERSITY OF SOUTHAMPTON
Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
their development of research and teaching within either the Human Development and Health school or Cancer Sciences school of the Faculty of Medicine, University of Southampton. In this post-doctoral role
-
Innovation is the lifeblood of the University of Southampton. Powered by world-class research, we enable spin-out companies across the country, enabling the development of products and services
-
WorldPop Senior Leadership Team developing a financial sustainability plan for WorldPop helping the group achieve its strategic financial objectives. The successful candidate will have experience in
-
BA Human Geography programmes, supporting and mentoring taught students, as well as contributing to the smooth running of the School. The appointment will be made at Level 4, Spine Point 31. There is
-
support faculty objectives by working on the development of the faculty marketing plan and managing its implementation, collaborating with a wide range of academic and marketing stakeholders to bring
-
are seeking a collaborative and motivated scientist to work on our newly funded programme developing next-generation, off-the-shelf immunotherapies for childhood cancers. This 12 month project will harness
-
. The successful candidate will contribute to an interdisciplinary research programme developing computational models to understand molecular interactions relevant to antimicrobial systems, biomolecular interfaces
-
are seeking a collaborative and motivated scientist to work on our newly funded programme developing next-generation, off-the-shelf immunotherapies for childhood cancers. This 12 month project will harness
-
We are seeking highly motivated post-doctoral researchers of high calibre to join our research program working in the area of electronic textiles. The role is suited to candidates from either
-
postdoctoral scientist to work on our Blood Cancer UK-funded programme developing next-generation, off-the-shelf immunotherapies for acute myeloid leukaemia (AML). This three-year project will harness cytotoxic